Exploratory study to evaluate the effect and safety of CIGB 500 in seriously ill patients with shock |
VSSPs in renal carcinoma. |
To evaluate the immunogenicity and safety of SOBERANA® 02 and SOBERANA® Plus as booster of immunity against the omicrom variant of SARS-CoV-2, in adult subjects |
Phase III clinical trial: Dermofural®. Mild infection in diabetic foot ulcer |
Efficacy and safety of Jusvinza treatment in patients with acute respiratory distress syndrome. Phase II/III |
Dietzia safety study |
Effect and safety of the use of Viusid® on the quality of life of patients with Chronic Kidney Disease on Hemodialysis. |
Evaluation of the effectiveness of video games for attention intervention in school age boys and girls |
Nimotuzumab in the treatment of patients with acute respiratory difficulty syndrome (ARDS) |
Kardioli® nutritional supplement versus placebo in patients with chronic heart failure. Phase II. |
PROCTOKINASE in acute pelvic inflammatory disease |
Feasibility and Effectiveness - MAP Online Program - Emerging Adults - Phase II |
IVD in colon cancer |
Prebiotics and probiotics in the treatment of type 2 diabetes |
Nasal recombinant human interferon alfa-2b in ARI |
Jusvinza in Severe Patients with Acquired Community Pneumonia |
NeuroEPO in mild-moderate Alzheimer's disease amnesic variant |
NeuroEPO in mild-moderate Alzheimer's disease |
Sinopharm-SOBERANA COVID-Cienfuegos |
Nasalferon in ARI |